Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 1933-1940

  Schlögl, Haiko ^a   Kabisch, Stefan ^a   Horstmann, Annette ^a,b   Lohmann, Gabriele ^b   Müller, Karsten ^b   Lepsien, Jöran ^b   Busse Voigt, Franziska ^a   Kratzsch, Jürgen ^a   Pleger, Burkhard ^a,b   Villringer, Arno ^a,b   Stumvoll, Michael ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EXENDIN 4; PLACEBO;

ADULT; ARTICLE; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; FEEDING BEHAVIOR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HYPOTHALAMIC CONNECTIVITY; HYPOTHALAMUS; MALE; OBESITY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALGORITHMS; BLOOD GLUCOSE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENERGY INTAKE; HUMANS; HYPOTHALAMUS; INSULIN; MAGNETIC RESONANCE IMAGING; MALE; PEPTIDES; VENOMS; YOUNG ADULT;

EID: 84885977398     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1925     Document Type: Article

References (40)

1. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 2007;87:1409-1439
2. Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 1998;101:515-520
3. Sze L, Purtell L, Jenkins A, et al. Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome. J Clin Endocrinol Metab 2011;96:E1314-E1319
4. Dushay J, Gao C, Gopalakrishnan GS, et al. Short-termexenatide treatment leads to significant weight loss in a subset of obese women without diabetes. Diabetes Care 2012;35:4-11
5. Campos RV, Lee YC, Drucker DJ. Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 1994;134:2156-2164
6. Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 1997;77:257-270
7. Washington MC, Raboin SJ, Thompson W, Larsen CJ, Sayegh AI. Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor. Brain Res 2010;1344:124-133
8. Fry M, Ferguson AV. The sensory circumventricular organs: brain targets for circulating signals controlling ingestive behavior. Physiol Behav 2007;91:413-423
9. Baroncini M, Jissendi P, Balland E, et al. MRI atlas of the human hypothalamus. Neuroimage 2012;59:168-180
10. Schloegl H, Percik R, Horstmann A, Villringer A, Stumvoll M. Peptide hormone regulating appetitedfocus on neuroimaging studies in humans. Diabetes Metab Res Rev 2011;27:104-112
11. Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature 2006;443:289-295
12. Parkinson JR, Chaudhri OB, Kuo YT, et al. Differential patterns of neuronal activation in the brainstem and hypothalamus following peripheral injection of GLP-1, oxyntomodulin and lithium chloride in mice detected by manganese-enhanced magnetic resonance imaging (MEMRI). Neuroimage 2009;44:1022-1031
13. Rodriquez De Fonseca F, Navarro M, Alvarez E, et al. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism 2000;49: 709-717
14. Kastin AJ, Akerstrom V. Entry of exendin- 4 into brain is rapid but may be limited at high doses. Int J Obes Relat Metab Disord 2003;27:313-318
15. Baraboi ED, St-Pierre DH, Shooner J, Timofeeva E, Richard D. Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4. Am J Physiol Regul Integr Comp Physiol 2011; 301:R1011-R1024
16. Batterham RL, ffytche DH, Rosenthal JM, et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007;450: 106-109
17. Malik S, McGlone F, Bedrossian D, Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 2008;7:400-409
18. De Silva A, Salem V, Long CJ, et al. The gut hormones PYY 3-36 and GLP-1 7-36 amiDe reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab 2011;14:700-706
19. Fletcher PC, Napolitano A, Skeggs A, et al. Distinct modulatory effects of satiety and sibutramine on brain responses to food images in humans: a double dissociation across hypothalamus, amygdala, and ventral striatum. J Neurosci 2010;30: 14346-14355
20. Van De Sande-Lee S, Pereira FR, Cintra DE, et al. Partial reversibility of hypothalamic dysfunction and changes in brain activity after body mass reduction in obese subjects. Diabetes 2011;60:1699-1704
21. Faulconbridge LF, Hayes MR. Regulation of energy balance and body weight by the brain: a distributed system prone to disruption. Psychiatr Clin North Am 2011; 34:733-745
22. Dickson SL, Shirazi RH, Hansson C, Bergquist F,NissbrandtH, SkibickaKP.The glucagon-like peptiDe 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci 2012;32:4812-4820
23. Segal JB, Dy SM, Millman EA, Herbert R, Bass EB, Wu A. Diffusion into use of exenatiDe for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy. Clin Ther 2007;29:1784-1794
24. Degn KB, Brock B, Juhl CB, et al. Effect of intravenous infusion of exenatiDe (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia. Diabetes 2004;53: 2397-2403
25. Egan JM, Clocquet AR, Elahi D. The insulinotropic effect of acute exendin-4 administered to humans: comparison of nondiabetic state to type 2 diabetes. J Clin Endocrinol Metab 2002;87:1282-1290
26. Fineman M, Flanagan S, Taylor K, et al. Pharmacokinetics and pharmacodynamics of exenatiDe extended-release after single and multiple dosing. Clin Pharmacokinet 2011;50:65-74
27. Kanoski SE, Rupprecht LE, Fortin SM, De Jonghe BC,HayesMR. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide. Neuropharmacology 2012;62:1916-1927
28. Brickenkamp R. Test d2. Göttingen, Hogrefe, 2002
29. Halstead WC. Brain and intelligence. Chicago, University of Chicago Press, 1947
30. Conway AR, Kane MJ, Bunting MF, Hambrick DZ, Wilhelm O, Engle RW. Working memory span tasks: A methodological review and user's guide. Psychon Bull Rev 2005;12:769-786
31. Lohmann G, Muller K, Bosch V, Mentzel H, Hessler S, Chen L, Zysset S, von Cramon DY. LIPSIA-a new software system for the evaluation of functional magnetic resonance images of the human brain. Comput Med Imaging Graph2001; 25:449-457
32. Lohmann G,Margulies DS, Horstmann A, et al. Eigenvector centrality mapping for analyzing connectivity patterns in fMRI data of the human brain. PLoS One 2010; 5:e10232
33. Langville H, Meyer C. Google's PageRank and Beyond: The Science of Search Engine Rankings. Princeton, Princeton University Press, 2006
34. SPM: statistical parametric mapping [Internet], c1994-2012. London, The FIL Methods Group. Available from http:// www.fil.ion.ucl.ac.uk/spm. Accessed 8 January 2013
35. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 1996;4:58-73
36. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlasbased interrogation of fMRI data sets. Neuroimage 2003;19:1233-1239
37. Maldjian JA, Laurienti PJ, Burdette JH. Precentral gyrus discrepancy in electronic versions of the Talairach atlas. Neuroimage 2004;21:450-455
38. Mazoyer B. In memoriam: Jean Talairach (1911-2007): a life in stereotaxy. Hum Brain Mapp 2008;29:250-252
39. Centers for Disease Control and Prevention (CDC). Trends in intake of energy and macronutrientsdUnited States, 1971- 2000. MMWR Morb Mortal Wkly Rep 2004;53:80-82
40. Kringelbach ML. Food for thought: hedonic experience beyond homeostasis in the human brain. Neuroscience 2004; 126:807-819